Myocardial Perfusion
Conditions
Keywords
99mTc-Sestamibi, thallium-201, semiconductor camera
Brief summary
The purpose is to demonstrate the concordance of diagnostic information obtained with: 1. a conventional examination with 2 distinct recordings on D.SPECT camera after 99mTc-sestamibi injections, the first post-stress and the second at rest, 2 to 3 hours later, and 2. a double isotope examination with a supplementary recording after injection of a little activity of thallium-201 at rest after the first recording and before the second injection of 99mTc-sestamibi for conventional recording at rest, in patients showing abnormalities of myocardial perfusion in stress myocardial tomoscintigraphy.
Detailed description
Myocardial perfusion tomoscintigraphy is very used for diagnosis and characterization of abnormalities of stress and rest myocardial perfusion. This examination can be performed with semiconductor gamma cameras that are more performant than conventional cameras regarding spatial resolution, detection sensitivity and energy resolution. The amelioration of energy resolution could allow the realization of simultaneous recordings of a dye injected at rest and another injected during stress (double isotope recording), while conventional examination needs 2 different recordings, stress and rest, separated from several hours. In this study patients undergo a conventional examination with D.SPECT camera with 2 recordings, the first after injection of a little activity of 99mTc-sestamibi at stress (≤ 100 MBq) and the second, 2 hours later, after injection at rest of a 3 time bigger activity of 99mTc-sestamibi (≤ 300 MBq). An activity of thallium-201(≤ 50 MBq) is injected at rest after the first recording of stress. 5 minutes later, a supplementary double isotope recording is realized with D.SPECT camera (99mTc-Sestamibi-stress / thallium201-rest). The demonstration of the hypothesis of this study could considerably diminish the duration of the examination (from 3 to 4 hours to less than 1 hour).
Interventions
PROCEDURETomoscintigraphy with D.SPECT camera (SPECTRUM Dynamics®, Israel)
* During stress test, intravenous injection of 99mTc-Sestamibi (between 80 and 150 MBq according to weight) in patient * Stress conventional acquisition with D.SPECT camera 20 min after injection * 60 min after 99mTc-Sestamibi injection, rest injection of thallium-201 (50% activity of stress 99mTc-Sestamibi) * double isotope acquisition 5 min after thallium-201 injection * injection of 99mTc-Sestamibi at rest (activity 3 times higher), after 2 hours from first 99mTc-Sestamibi injection * rest conventional acquisition 20 min later
DRUG99mTc-Sestamibi
First intravenous injection between 80 and 150 MBq according to patient weight and second injection with 3-time-higher activity, 2 hours after the first For tomoscintigraphy
DRUGThallium-201
Injection of thallium-201 (50% activity of first 99mTc-Sestamibi injection) For tomoscintigraphy
Sponsors
Central Hospital, Nancy, France
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* \> 18, without guardianship, signed informed consent * Without contraindication for myocardial perfusion tomoscintigraphy and stress technique (dipyridamole and/or effort), according to common criteria to French Societies of Cardiology and Nuclear Medicine, as it is requested for all patients needing this routine examination * Not in life-and-death emergency, with a stable clinical state (without cardiac insufficiency or instable coronary, without hypertension not well-stabilized under treatment) * Effective contraceptive method for women of childbearing potential * Weight ≤ 100 kg (\> 100 kg patients need higher injected activities in order to obtain adequate image quality) * Perfusion abnormalities on stress images
Exclusion criteria
* \< 18 * Contraindications to stress test (effort and/or dipyridamole) * Hypersensibility to thallium201 chloride or one of excipients * Claustrophobic patient or incapable to stay lying down for 30 minutes * Pregnancy or doubt of pregnancy * Breastfeeding woman * Weight \> 100 kg * Non affiliation to social security plan
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of images obtained with double isotope tomoscintigraphy and conventional tomoscintigraphy | day 0 | Bad; medium; good; very good |
| Nature of observed abnormalities obtained with double isotope tomoscintigraphy and conventional tomoscintigraphy | day 0 | Without abnormalities or artefacts (normal); with rest reversible abnormalities (ischemia); with rest non reversible abnormalities (infarction) |
Countries
France
Outcome results
None listed